GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
GRAIL (NASDAQ:GRAL), a healthcare company focused on early cancer detection, has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company's management will deliver their presentation on Tuesday, September 9 at 1:50 p.m. ET.
Investors can access both the live presentation and replay through GRAIL's investor relations website at investors.grail.com. The webcast recording will remain available for a minimum of 30 days following the event.
GRAIL (NASDAQ:GRAL), azienda sanitaria specializzata nella diagnosi precoce del cancro, parteciperà al Morgan Stanley 23rd Annual Global Healthcare Conference. La direzione terrà la presentazione martedì 9 settembre alle 13:50 ET.
Gli investitori potranno seguire la presentazione in diretta e rivederla sul sito delle relazioni con gli investitori di GRAIL all'indirizzo investors.grail.com. La registrazione webcast sarà disponibile per almeno 30 giorni dopo l'evento.
GRAIL (NASDAQ:GRAL), una compañía de salud centrada en la detección temprana del cáncer, ha anunciado su participación en el Morgan Stanley 23rd Annual Global Healthcare Conference. La dirección ofrecerá su presentación el martes 9 de septiembre a las 1:50 p.m. ET.
Los inversores podrán acceder a la transmisión en vivo y a la repetición a través del sitio de relaciones con inversores de GRAIL en investors.grail.com. La grabación del webcast permanecerá disponible al menos 30 días tras el evento.
GRAIL (NASDAQ:GRAL)은 조기 암 진단에 주력하는 의료 기업으로, Morgan Stanley 23rd Annual Global Healthcare Conference에 참여한다고 발표했습니다. 회사 경영진의 발표는 현지시간 화요일, 9월 9일 오후 1시 50분(ET)에 진행됩니다.
투자자들은 GRAIL의 투자자 관계 웹사이트 investors.grail.com에서 라이브 프레젠테이션과 다시보기를 시청할 수 있습니다. 웹캐스트 녹화는 행사 종료 후 최소 30일 동안 제공됩니다.
GRAIL (NASDAQ:GRAL), entreprise de santé spécialisée dans la détection précoce du cancer, a annoncé sa participation à la Morgan Stanley 23rd Annual Global Healthcare Conference. La direction présentera son exposé le mardi 9 septembre à 13h50 (ET).
Les investisseurs pourront accéder à la présentation en direct et au replay via le site des relations investisseurs de GRAIL à l'adresse investors.grail.com. L'enregistrement du webcast restera disponible au minimum 30 jours après l'événement.
GRAIL (NASDAQ:GRAL), ein Gesundheitsunternehmen, das sich auf die Früherkennung von Krebs spezialisiert hat, hat seine Teilnahme an der Morgan Stanley 23rd Annual Global Healthcare Conference angekündigt. Das Management wird seine Präsentation am Dienstag, 9. September um 13:50 Uhr ET halten.
Investoren können die Live-Präsentation und die Aufzeichnung auf der Investor-Relations-Website von GRAIL unter investors.grail.com abrufen. Die Webcast-Aufzeichnung wird mindestens 30 Tage nach der Veranstaltung verfügbar sein.
- None.
- None.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-morgan-stanley-23rd-annual-global-healthcare-conference-302538075.html
SOURCE GRAIL, Inc.
FAQ
When is GRAIL (GRAL) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors watch GRAIL's Morgan Stanley conference presentation?
How long will GRAIL's Morgan Stanley conference presentation be available for replay?
What is GRAIL's main business focus?
